Stay updated on Cabiralizumab Combo in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The record describes a completed Phase 2 study of cabiralizumab and nivolumab, alone or with chemotherapy, for advanced pancreatic cancer. It provides the study design, eligibility criteria, locations, outcome measures, and reported record dates.
    Difference
    93%
    Check dated 2026-11-10T13:54:09.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer shows an updated ClinicalTrials.gov site revision; the study record remains unavailable and displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T13:58:05.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-20T13:41:45.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T14:48:22.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Deleted 403 Forbidden page content and the Home link from the study record page. This indicates the page is no longer blocked and navigation is simplified, allowing access to the trial details.
    Difference
    0.5%
    Check dated 2026-09-29T16:08:53.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden response instead of the study record. This indicates the record is currently inaccessible.
    Difference
    21%
    Check dated 2026-09-22T21:00:40.000Z thumbnail image

Stay in the know with updates to Cabiralizumab Combo in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabiralizumab Combo in Pancreatic Cancer Clinical Trial page.